Infliximab (IFX) is an anti-tumor necrosis factorchimeric antibody that is effective for treatment ofautoimmune disorders such as Crohn's disease andulcerative col
AIM: To study host gene expression and number of immune cells in liver tissues from patients withfulminant hepatitis E (FH-E).METHODS: Microarray-based expression p